Boston Family Office’s Clorox CLX Stock Holding History

Boston Family Office’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67M	Sell	16,137 -1,066	-6%	-$121K	0.11%	136
2025 Q4	$1.74M	Sell	17,203 -7,260	-30%	-$788K	0.11%	130
2025 Q3	$3.02M	Buy	24,463 +2,307	+10%	+$286K	0.19%	94
2025 Q2	$2.66M	Sell	22,156 -114	-0.5%	-$15.2K	0.18%	100
2025 Q1	$3.28M	Buy	22,270 +22	+0.1%	+$3.36K	0.23%	88
2024 Q4	$3.61M	Buy	22,248 +20	+0.1%	+$3.27K	0.25%	84
2024 Q3	$3.62M	Sell	22,228 -877	-4%	-$130K	0.25%	85
2024 Q2	$3.15M	Sell	23,105 -309	-1%	-$42.9K	0.23%	89
2024 Q1	$3.58M	Buy	23,414 +407	+2%	+$60.8K	0.26%	80
2023 Q4	$3.28M	Buy	23,007 +661	+3%	+$88.1K	0.25%	79
2023 Q3	$2.93M	Buy	22,346 +49	+0.2%	+$7.45K	0.24%	81
2023 Q2	$3.55M	Buy	22,297 +2,778	+14%	+$448K	0.27%	77
2023 Q1	$3.09M	Buy	19,519 +3,552	+22%	+$533K	0.25%	79
2022 Q4	$2.24M	Sell	15,967 -187	-1%	-$26.5K	0.19%	104
2022 Q3	$2.07M	Sell	16,154 -1,127	-7%	-$163K	0.18%	100
2022 Q2	$2.44M	Sell	17,281 -625	-3%	-$89.3K	0.2%	96
2022 Q1	$2.49M	Sell	17,906 -550	-3%	-$84.3K	0.18%	102
2021 Q4	$3.22M	Sell	18,456 -3,269	-15%	-$545K	0.21%	92
2021 Q3	$3.6M	Sell	21,725 -1,845	-8%	-$318K	0.26%	83
2021 Q2	$4.24M	Sell	23,570 -40	-0.2%	-$7.3K	0.3%	77
2021 Q1	$4.55M	Sell	23,610 -750	-3%	-$144K	0.34%	74
2020 Q4	$4.92M	Sell	24,360 -1,050	-4%	-$217K	0.38%	69
2020 Q3	$5.34M	Sell	25,410 -5	-0%	-$1.11K	0.48%	55
2020 Q2	$5.58M	Sell	25,415 -1,057	-4%	-$211K	0.54%	54
2020 Q1	$4.59M	Sell	26,472 -1,051	-4%	-$174K	0.54%	54
2019 Q4	$4.23M	Sell	27,523 -493	-2%	-$73.7K	0.4%	69
2019 Q3	$4.25M	Sell	28,016 -94	-0.3%	-$14.9K	0.44%	65
2019 Q2	$4.3M	Buy	28,110 +256	+0.9%	+$39.1K	0.45%	62
2019 Q1	$4.47M	Buy	27,854 +210	+0.8%	+$32.6K	0.48%	61
2018 Q4	$4.26M	Buy	27,644 +380	+1%	+$59.2K	0.53%	56
2018 Q3	$4.1M	Buy	27,264 +25	+0.1%	+$3.55K	0.43%	69
2018 Q2	$3.68M	Buy	27,239 +500	+2%	+$61.7K	0.42%	75
2018 Q1	$3.56M	Buy	26,739 +420	+2%	+$56.4K	0.41%	79
2017 Q4	$3.92M	Sell	26,319 -690	-3%	-$93.9K	0.43%	75
2017 Q3	$3.56M	Buy	27,009 +1,040	+4%	+$140K	0.4%	79
2017 Q2	$3.46M	Buy	25,969 +210	+0.8%	+$28.3K	0.41%	77
2017 Q1	$3.47M	Buy	25,759 +5,345	+26%	+$692K	0.43%	74
2016 Q4	$2.45M	Buy	20,414 +2,400	+13%	+$283K	0.32%	91
2016 Q3	$2.25M	Buy	18,014 +170	+1%	+$22.3K	0.29%	96
2016 Q2	$2.47M	Buy	17,844 +1,980	+12%	+$257K	0.32%	90
2016 Q1	$2M	Buy	15,864 +435	+3%	+$55.3K	0.26%	103
2015 Q4	$1.96M	Buy	15,429 +430	+3%	+$53.4K	0.27%	108
2015 Q3	$1.73M	Buy	14,999 +1,455	+11%	+$163K	0.24%	109
2015 Q2	$1.41M	Hold	13,544	–	–	0.18%	125
2015 Q1	$1.5M	Sell	13,544 -10	-0.1%	-$1.09K	0.19%	121
2014 Q4	$1.41M	Hold	13,554	–	–	0.18%	128
2014 Q3	$1.3M	Hold	13,554	–	–	0.17%	129
2014 Q2	$1.24M	Buy	13,554 +55	+0.4%	+$4.93K	0.16%	131
2014 Q1	$1.19M	Buy	13,499 +275	+2%	+$24.1K	0.16%	134
2013 Q4	$1.23M	Buy	13,224 +1,125	+9%	+$101K	0.16%	133
2013 Q3	$989K	Sell	12,099 -600	-5%	-$50.7K	0.14%	141
2013 Q2	$1.06M	Buy	+12,699	New	+$1.09M	0.16%	135

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Boston Family Office's CLX Position: Q1 2026 in Review

Boston Family Office reduced its Clorox (CLX) stake by 6.2% in Q1 2026, selling an estimated $121K and leaving 16,137 shares worth $1.67M. The position accounts for 0.11% of the portfolio, ranked #136.

Boston Family Office first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.58M in Q2 2020. 1,082 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Boston Family Office held 16,137 shares of Clorox worth $1.67M as of Q1 2026.
Boston Family Office sold 1,066 Clorox shares in Q1 2026, an estimated $121K.
Clorox made up 0.11% of Boston Family Office's portfolio in Q1 2026, its #136 holding.
Boston Family Office first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
Boston Family Office's Clorox position peaked at $5.58M in Q2 2020.
1,082 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.